首页> 美国卫生研究院文献>Cancers >Surviving Elderly Patients with Head-and-Neck Squamous Cell Carcinoma—What Is the Long-Term Quality of Life after Curative Radiotherapy?
【2h】

Surviving Elderly Patients with Head-and-Neck Squamous Cell Carcinoma—What Is the Long-Term Quality of Life after Curative Radiotherapy?

机译:幸存的老年患者头颈鳞状细胞癌 - 治疗放疗后的长期生活质量是什么?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

As the long-term effects of radiotherapy on the quality of life (QoL) of elderly (≥65 years) patients with head-and-neck squamous cell carcinoma (HNSCC) are not well understood, we examined the QoL of surviving elderly HNSCC patients who were treated with radiotherapy. In this cross-sectional study, long-term quality of life (QoL) at ≥1 year after radiotherapy completion was comparable to the general German population of the same age and gender. Patients whose HNSCC was induced by human papillomavirus (HPV) exhibited a superior long-term global QoL than elderly patients with HPV-negative tumors. Interestingly, concomitant chemotherapy administration did not deteriorate patients’ global QoL in the long-term. We did not observe differences in patients’ health-related QoL in dependence of the treatment (definitive versus adjuvant (chemo)radiotherapy). Our data are important for clinicians treating elderly HNSCC patients as well as for elderly HNSCC patients themselves.
机译:由于放射治疗对老年人(≥65年)的生命质量(QOL)的长期影响,患有头颈鳞状细胞癌(HNSCC)的患者尚不清楚,我们检查了幸存的老人HNSCC患者的QoL谁被放射治疗治疗。在这种横断面研究中,放射治疗完成后≥1年的长期生活质量(QOL)与相同年龄和性别的普通普通人口相当。 HNSCC由人乳头瘤病毒(HPV)诱导的患者表现出比老年人HPV阴性肿瘤的老年患者的高级长期全球QoL。有趣的是,伴随的化疗管理在长期内并未恶化了患者的全球QOL。我们没有观察患者健康相关QOL的差异,依赖于治疗(明确与佐剂(化疗)放射治疗)。我们的数据对于治疗老年HNSCC患者以及老年人HNSCC患者本身的临床医生很重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号